Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.3K
Overview
86.3K
Humoral Immune Responses01:36

Humoral Immune Responses

86.1K
Overview
86.1K
Vaccines01:21

Vaccines

42
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42
Viral Structure00:56

Viral Structure

76.2K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
76.2K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A homozygous missense variant, p.Ser166Leu in the <i>PRPF40B</i> gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor.

Frontiers in neurology·2026
Same author

Experimental and clinical evidence on radiofrequency electromagnetic field effects on the blood-brain barrier: a scoping review.

Physics in medicine and biology·2026
Same author

CNDP1 and Diabetic Kidney Disease: From Genetic Susceptibility to Therapeutic Targeting.

Genes·2026
Same author

β-Catenin stabilization protects against alveolar hemorrhage through amphiregulin- and BATF-mediated Tregs.

JCI insight·2026
Same author

A new approach for elimination of apoptotic resistance caused by MDM2/MDMX amplification in chronic lymphocytic leukemia: combination of ALRN-6924 and radiofrequency exposure.

Medical oncology (Northwood, London, England)·2025
Same author

Betanin-Based Contrast Agents for MRI: A Preliminary Experimental Study.

Journal of magnetic resonance imaging : JMRI·2025

Related Experiment Video

Updated: Mar 30, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K

Virus-like nanostructures for tuning immune response.

Rashad Mammadov1, Goksu Cinar1, Nuray Gunduz1

  • 1Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, Ankara 06800, Turkey.

Scientific Reports
|November 19, 2015
PubMed
Summary

Researchers explored how peptide nanostructures shaped like spheres and rods, carrying viral DNA signatures, influence immune responses. Nanofibers, a key shape, significantly enhanced immune responses against intracellular pathogens and improved vaccine efficacy.

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Mar 30, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Nanotechnology
  • Immunology
  • Vaccine Development

Background:

  • Synthetic vaccines use viral signatures to elicit immune responses.
  • The impact of physical signatures on immune response is less understood than biochemical signatures.
  • Peptide nanostructures offer a platform to investigate physical cues in immune modulation.

Purpose of the Study:

  • To investigate the immune-modulating potential of peptide nanostructures with varying physical shapes (0D and 1D).
  • To evaluate the role of nanostructure shape in directing immune responses towards a Th1 phenotype.
  • To assess the efficacy of nanostructure-CpG complexes as vaccine delivery systems.

Main Methods:

  • Fabrication of zero-dimensional (nanospheres) and one-dimensional (nanofibers) self-assembled peptide nanostructures.
  • Incorporation of unmethylated CpG motifs (cytosine-guanine oligodeoxynucleotides) into nanostructures.
  • In vitro assessment of immune cell uptake (dendritic cells) and immune response phenotype (Th1 polarization).
  • In vivo evaluation of antigen-specific IgG production and stability against nuclease degradation.

Main Results:

  • Nanofibrous structures significantly directed immune response towards the Th1 phenotype compared to nanospheres and CpG ODN alone.
  • Enhanced uptake of nanofibers into dendritic cells was observed.
  • Peptide nanostructures improved the chemical stability of CpG ODN against degradation.
  • In vivo studies demonstrated over 10-fold enhanced antigen-specific IgG production with nanofibers compared to CpG ODN alone.

Conclusions:

  • The physical shape of peptide nanostructures can effectively modulate the nature of the immune response.
  • Nanofibers carrying CpG motifs show superior potential for enhancing Th1-biased immune responses and vaccine efficacy.
  • Shape-dependent delivery systems represent a novel strategy for optimizing synthetic vaccines.